Complete or partial remission · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in complete or partial remission Time frame: 24 weeks to end of treatment compared with oral steroids alone (moderate certainty).
1 finding from 1 review
Relapse · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in relapse Time frame: 24 weeks compared with oral steroids alone (low certainty).
1 finding from 1 review
Adverse events: death · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in adverse events: death compared with oral steroids alone (low certainty).
1 finding from 1 review
Acute kidney injury · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in adverse events: acute kidney injury compared with oral steroids alone (low certainty).
1 finding from 1 review
Adverse events: new‐onset glucose intolerance · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in adverse events: new‐onset glucose intolerance compared with oral steroids alone (low certainty).
1 finding from 1 review
Relapse · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes relapse during compared with no specific treatment (very low certainty).
1 finding from 1 review
Adverse events: avascular necrosis · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes adverse events: avascular necrosis compared with no specific treatment (very low certainty).
1 finding from 1 review
Doubling serum creatinine · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes adverse events: doubling serum creatinine compared with no specific treatment (very low certainty).
1 finding from 1 review
Adverse events: kidney failure · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes adverse events: kidney failure compared with no specific treatment (very low certainty).
1 finding from 1 review
Complete remission · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether intravenous ± oral steroids changes complete remission Time frame: 2 to 28 months compared with oral steroids alone (very low certainty).
1 finding from 1 review
Complete or partial remission · minimal change disease in adults with nephrotic syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether intravenous ± oral steroids changes relapse during compared with oral steroids alone (very low certainty).
1 finding from 1 review
Complete remission of proteinuria · adults with FSGS
Cyclosporin may leads to higher complete remission of proteinuria compared with different comparators (low certainty).
1 finding from 1 review
Partial remission of proteinuria · adults with FSGS
Cyclosporin showed no clear difference in partial remission of proteinuria compared with different comparators (low certainty).
1 finding from 1 review
Complete or partial remission · adults with FSGS
Cyclosporin may leads to higher complete or partial remission compared with different comparators (low certainty).
1 finding from 1 review
Chronic kidney disease · adults with FSGS
Cyclosporin showed no clear difference in chronic kidney disease compared with different comparators (low certainty).
1 finding from 1 review
Kidney failure · adults with FSGS
Cyclosporin showed no clear difference in kidney failure compared with different comparators (low certainty).
1 finding from 1 review
Adverse events: hypertension · adults with FSGS
1 finding from 1 review
Adverse effects: infection · adults with FSGS
1 finding from 1 review
Self‐efficacy · people with CKD
1 finding from 1 review